What is the appropriate evaluation and acute management for a patient with marked hyperglycemia, elevated BUN, elevated creatinine, hypernatremia, hyperkalemia, low CO₂, increased anion gap, high serum osmolality, and an eGFR of 34 mL/min/1.73 m² consistent with acute hyperosmolar hyperglycemic state and acute kidney injury?

Hyperosmolar Hyperglycemic State with Acute Kidney Injury

This patient requires immediate aggressive IV fluid resuscitation with 0.9% sodium chloride, followed by fixed-rate insulin infusion only after osmolality begins declining with fluids alone, while urgently identifying and treating the underlying precipitant.

Diagnostic Confirmation

This presentation is classic for Hyperosmolar Hyperglycemic State (HHS) with concurrent Acute Kidney Injury (AKI):

• HHS criteria met 1, 2:

  • Marked hyperglycemia (289 mg/dL, though typically ≥600 mg/dL in classic HHS)
  • Serum osmolality 321.2 mOsm/kg (>320 diagnostic threshold)
  • Elevated anion gap (20.0) with low CO₂ (18 mEq/L)
  • Hypernatremia (146 mmol/L)

• AKI Stage 3 3:

  • Creatinine 2.06 mg/dL with eGFR 34 mL/min/1.73 m²
  • BUN 70.3 mg/dL with BUN/Cr ratio 34.1 (suggests prerenal component from severe volume depletion)

Critical caveat: The glucose is lower than typical HHS (usually ≥600 mg/dL), suggesting either euglycemic hyperosmolar hypernatremic state (a variant with higher mortality 4) or early/mixed presentation. The elevated osmolality and hypernatremia are the dominant pathophysiology here.

Immediate Management Algorithm (First 0-6 Hours)

1. Fluid Resuscitation - FIRST PRIORITY 1, 5

Start immediately with 0.9% sodium chloride:

• Initial rate: 15-20 mL/kg/h (approximately 1-1.5 L/h for average adult)
• Target: Replace approximately 50% of estimated fluid deficit within first 12 hours
• Estimated fluid losses in HHS: 100-220 mL/kg body weight

Monitor closely for:

• Osmolality decline of 3-8 mOsm/kg/h (JBDS guideline) 1
• Urine output target: ≥0.5 mL/kg/h
• Avoid fluid overload, especially given age and potential cardiac comorbidities

2. Insulin Therapy - DELAYED START 1, 5

Critical distinction from DKA: Do NOT start insulin immediately in pure HHS.

• Wait to start insulin until osmolality stops declining with IV fluids alone
• Once indicated, use fixed-rate IV insulin infusion (FRIII): 0.05 units/kg/h 1
• Increase by 1 unit/h if glucose not declining adequately
• Target glucose 10-15 mmol/L (180-270 mg/dL) in first 24 hours—NOT normoglycemia

Rationale: Premature insulin risks precipitous osmolality decline and cerebral edema. Fluids alone will lower glucose initially through dilution and improved renal perfusion.

3. Electrolyte Management

Potassium (current: 5.3 mmol/L, hemolyzed specimen):

• Repeat immediately with non-hemolyzed sample
• If truly elevated: Hold potassium replacement initially
• Once <5.0 mmol/L and insulin started: Aggressive replacement needed (hypokalaemia occurs in ~50% during treatment) 6
• Target: 4.0-5.0 mmol/L

Sodium (current: 146 mmol/L):

• Calculate corrected sodium: Add 1.6 mEq/L for every 100 mg/dL glucose >100 mg/dL
• Corrected Na = 146 + [1.6 × (289-100)/100] ≈ 149 mEq/L
• Continue 0.9% saline despite hypernatremia—this is appropriate for HHS 1
• Monitor sodium decline: Should not exceed 10-12 mEq/L per 24 hours to prevent osmotic demyelination

4. Identify and Treat Precipitant 7, 1

Most common triggers:

• Infection (most common—check for pneumonia, UTI, sepsis)
• Acute coronary syndrome
• Stroke
• Medication non-adherence
• New-onset diabetes

Immediate workup:

• Blood cultures, urinalysis, chest X-ray
• ECG and troponin (if cardiac symptoms)
• CT head (if altered mental status or focal deficits)

Medication Review - CRITICAL 8, 3

STOP immediately:

• Metformin: Contraindicated with eGFR <30 mL/min/1.73 m² 8
• NSAIDs: Nephrotoxic in AKI
• ACE inhibitors/ARBs: Temporarily discontinue during acute illness with AKI 8, 3
• Diuretics: Worsen volume depletion
• SGLT2 inhibitors (if on them): Stop during acute illness

Monitoring Requirements (First 24 Hours)

Hourly:

• Point-of-care glucose
• Vital signs
• Urine output

Every 2-4 hours:

• Serum osmolality (calculate: 2×Na + glucose + BUN)
• Electrolytes (Na, K, Cl, CO₂)
• Creatinine

Every 4-6 hours:

• Anion gap
• Venous blood gas (if acidosis present)

Resolution Criteria 1

• Osmolality <300 mOsm/kg
• Hypovolemia corrected (urine output ≥0.5 mL/kg/h)
• Blood glucose <15 mmol/L (270 mg/dL)
• Mental status returned to baseline
• Anion gap normalized

Common Pitfalls to Avoid

1. Starting insulin too early: This is HHS, not DKA—fluids first 1, 5

2. Correcting osmolality too rapidly: Risk of cerebral edema and osmotic demyelination. Target 3-8 mOsm/kg/h decline 1

3. Ignoring corrected sodium: Raw sodium underestimates true hypernatremia in hyperglycemia 9

4. Continuing metformin: Absolute contraindication with this degree of renal impairment—risk of lactic acidosis 8

5. Aggressive glucose lowering: Target is 180-270 mg/dL in first 24 hours, NOT normoglycemia 10, 1

6. Inadequate potassium monitoring: Hypokalaemia during treatment is common and life-threatening 6

Disposition

ICU admission required 11, 2:

• Severe metabolic derangement
• AKI Stage 3
• Requires continuous IV insulin infusion
• High mortality risk (HHS mortality 5-20%, higher with AKI) 4, 12

Transition Planning (24-72 Hours)

Once stabilized:

• Transition to subcutaneous basal-bolus insulin 2-4 hours before stopping IV insulin 7
• Estimate total daily dose from average hourly IV insulin × 24
• Diabetes education and medication adherence counseling
• Nephrology follow-up for AKI (may represent acute-on-chronic kidney disease)
• Reassess metformin safety once eGFR >45 mL/min/1.73 m² 8